UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

α-Bungarotoxin Binding to Acetylcholine Receptor Membranes Studied by Low Angle X-Ray Diffraction

Biophysical journal, 2003-08, Vol.85 (2), p.943-953

2003

Volltextzugriff (PDF)

Lercanidipine: Short Plasma Half-Life, Long Duration of Action: A Molecular Model to Rationalize Its Pharmacokinetic Properties

Journal of cardiovascular pharmacology, 1997, Vol.29 Sup 1 (Sup 1), p.S19-S24

1997

Volltextzugriff (PDF)

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol

Neurobiology of aging, 1992-05, Vol.13 (3), p.413-419

1992

Volltextzugriff (PDF)

Lercanidipine: Short Plasma Half-life, Long Duration of Action and High Cholesterol tolerance: Updated Molecular Model to Rationalize its Pharmacokinetic Properties

Blood pressure, 1998, Vol.7 (1), p.10-17

G. HERBETTE, MICHELLE VECCHIARELLI, ABRAHAM SARTANI, AMEDEO LEONARDI, LEO

1998

Volltextzugriff (PDF)

Molecular interaction between lacidipine and biological membranes

Journal of hypertension, 1993-03, Vol.11 Suppl 1 (1), p.S13-S19

1993

Volltextzugriff (PDF)

X-ray Diffraction Analysis of Cytochrome P450 2B4 Reconstituted into Liposomes

Biochemistry (Easton), 1996-02, Vol.35 (5), p.1466-1474

1996

Volltextzugriff (PDF)

Structural Analysis of Drug Molecules in Biological Membranes

Biophysical journal, 1986, Vol.49 (1), p.91-94

1986

Volltextzugriff (PDF)

The Molecular Basis for Lacidipineʼs Unique Pharmacokinetics: Optimal Hydrophobicity Results in Membrane Interactions That May Facilitate the Treatment of Atherosclerosis

Journal of cardiovascular pharmacology, 1994, Vol.23 Suppl 5, p.S16-S25

1994

Volltextzugriff (PDF)

Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes

Journal of medicinal chemistry, 1991-03, Vol.34 (3), p.869-877

1991

Volltextzugriff (PDF)

Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interactions with biological membranes

Journal of medicinal chemistry, 1991-03, Vol.34 (3), p.869-877

1991

Volltextzugriff (PDF)

(Alpha)-Bungarotoxin binding to acetylcholine receptor membranes studied by low angle x-ray diffraction

Biophysical journal, 2003-08, Vol.85 (2), p.943

2003

Volltextzugriff (PDF)

Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: Lipid bilayer partitioning could occur before drug binding to receptors

Journal of molecular and cellular cardiology, 1989-02, Vol.21 (2), p.187-201

1989

Volltextzugriff (PDF)

Phospholipid fatty acyl chain asymmetry in the membrane bilayer of isolated skeletal muscle sarcoplasmic reticulum

Biochemistry (Easton), 1987-07, Vol.26 (15), p.4831-4836

1987

Volltextzugriff (PDF)

Membrane pathways for drug/ion channel interactions: Molecular basis for pharmacokinetic properties

Drug development research, 1994-11, Vol.33 (3), p.214-224

Herbette, Leo G.

1994

Volltextzugriff (PDF)

Lercanidipine: Short Plasma Half-life, Long Duration of Action and High Cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties

Blood pressure, 1998, Vol.7 (S2), p.10-17

1998

Volltextzugriff (PDF)

XaRay Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and I2aAmyloid Peptide Interactionsa

Annals of the New York Academy of Sciences, 1993-09, Vol.695 (1), p.54-58

1993

Volltextzugriff (PDF)

X-Ray Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and β-Amyloid Peptide Interactions

Annals of the New York Academy of Sciences, 1993-09, Vol.695 (1), p.54-58

1993

Volltextzugriff (PDF)

'Pharmacokinetic' and 'pharmacodynamic' design of lipophilic drugs based on a structural model for drug interactions with biological membranes

Pesticide Science, 1992, Vol.35 (4), p.363-368

Herbette, L.G

1992

Volltextzugriff (PDF)

Study of the topography of cannabinoids in model membranes using X-ray diffraction

Biochimica et biophysica acta, 1990-05, Vol.1024 (2), p.336-344

1990

Volltextzugriff (PDF)

X‐Ray Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and β‐Amyloid Peptide Interactionsa

Annals of the New York Academy of Sciences, 1993-09, Vol.695 (1), p.54-58

1993

Volltextzugriff (PDF)

Effects of hexagonal phase induction by dolichol on phospholipid membrane permeability and morphology

International journal of pharmaceutics, 1994-05, Vol.105 (3), p.259-272

1994

Volltextzugriff (PDF)

Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: Propranolol, nimodipine and amiodarone

Journal of molecular and cellular cardiology, 1988-05, Vol.20 (5), p.373-378

1988

Volltextzugriff (PDF)

Can altering serum cholesterol affect neurologic function?

Journal of molecular and cellular cardiology, 1991-11, Vol.23 (11), p.1339-1342

1991

Volltextzugriff (PDF)

Cholesterol significantly affects drug interactions with membranes

Pharmacochemistry Library, 1997, Vol.28, p.117-125

Herbette, Leo G.

1997

Volltextzugriff (PDF)

Single crystal X-ray structures of the two 4-heptadecyl derivatives of (1 R,5 S)-3,6,8-trioxabicylo[3.2.1]octane

Chemistry and physics of lipids, 1995-08, Vol.77 (1), p.99-112

1995

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(31)
Buchkapitel
(1)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

α-Bungarotoxin Binding to Acetylcholine Receptor Membranes Studied by Low Angle X-Ray Diffraction

Lercanidipine: Short Plasma Half-Life, Long Duration of Action: A Molecular Model to Rationalize Its Pharmacokinetic Properties

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol

Lercanidipine: Short Plasma Half-life, Long Duration of Action and High Cholesterol tolerance: Updated Molecular Model to Rationalize its Pharmacokinetic Properties

Molecular interaction between lacidipine and biological membranes

X-ray Diffraction Analysis of Cytochrome P450 2B4 Reconstituted into Liposomes

Structural Analysis of Drug Molecules in Biological Membranes

The Molecular Basis for Lacidipineʼs Unique Pharmacokinetics: Optimal Hydrophobicity Results in Membrane Interactions That May Facilitate the Treatment of Atherosclerosis

Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes

Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interactions with biological membranes

(Alpha)-Bungarotoxin binding to acetylcholine receptor membranes studied by low angle x-ray diffraction

Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: Lipid bilayer partitioning could occur before drug binding to receptors

Phospholipid fatty acyl chain asymmetry in the membrane bilayer of isolated skeletal muscle sarcoplasmic reticulum

Membrane pathways for drug/ion channel interactions: Molecular basis for pharmacokinetic properties

Lercanidipine: Short Plasma Half-life, Long Duration of Action and High Cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties

XaRay Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and I2aAmyloid Peptide Interactionsa

X-Ray Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and β-Amyloid Peptide Interactions

'Pharmacokinetic' and 'pharmacodynamic' design of lipophilic drugs based on a structural model for drug interactions with biological membranes

Study of the topography of cannabinoids in model membranes using X-ray diffraction

X‐Ray Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and β‐Amyloid Peptide Interactionsa

Effects of hexagonal phase induction by dolichol on phospholipid membrane permeability and morphology

Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: Propranolol, nimodipine and amiodarone

Can altering serum cholesterol affect neurologic function?

Cholesterol significantly affects drug interactions with membranes

Single crystal X-ray structures of the two 4-heptadecyl derivatives of (1 R,5 S)-3,6,8-trioxabicylo[3.2.1]octane

Suchergebnisse filtern